| 000 | 01011 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513232709.0 | ||
| 264 | 0 | _c20010614 | |
| 008 | 200106s 0 0 eng d | ||
| 022 | _a0176-3679 | ||
| 024 | 7 |
_a10.1055/s-2001-15188 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDeuschle, M | |
| 245 | 0 | 0 |
_aBenzodiazepine withdrawal-induced catatonia. _h[electronic resource] |
| 260 |
_bPharmacopsychiatry _cJan 2001 |
||
| 300 |
_a41-2 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Anxiety Agents _xadverse effects |
| 650 | 0 | 4 |
_aBromazepam _xadverse effects |
| 650 | 0 | 4 |
_aCatatonia _xchemically induced |
| 650 | 0 | 4 | _aElectroencephalography |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSubstance Withdrawal Syndrome _xpsychology |
| 700 | 1 | _aLederbogen, F | |
| 773 | 0 |
_tPharmacopsychiatry _gvol. 34 _gno. 1 _gp. 41-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2001-15188 _zAvailable from publisher's website |
| 999 |
_c11167238 _d11167238 |
||